nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ADRA1A—polycystic ovary syndrome	0.518	0.627	CbGaD
Dipivefrin—ADRB2—polycystic ovary syndrome	0.308	0.373	CbGaD
Dipivefrin—Bambuterol—ADRB2—polycystic ovary syndrome	0.00227	0.31	CrCbGaD
Dipivefrin—Epinephrine—ADRA1D—polycystic ovary syndrome	0.00138	0.188	CrCbGaD
Dipivefrin—Epinephrine—ADRB3—polycystic ovary syndrome	0.00124	0.169	CrCbGaD
Dipivefrin—Epinephrine—ADRA1B—polycystic ovary syndrome	0.00118	0.161	CrCbGaD
Dipivefrin—Epinephrine—ADRA1A—polycystic ovary syndrome	0.000793	0.108	CrCbGaD
Dipivefrin—Epinephrine—ADRB2—polycystic ovary syndrome	0.000472	0.0643	CrCbGaD
Dipivefrin—ACHE—adrenal gland—polycystic ovary syndrome	0.000307	0.0692	CbGeAlD
Dipivefrin—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000224	0.0505	CbGeAlD
Dipivefrin—ADRA2C—endometrium—polycystic ovary syndrome	0.0002	0.0451	CbGeAlD
Dipivefrin—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000189	0.0426	CbGeAlD
Dipivefrin—BCHE—endometrium—polycystic ovary syndrome	0.000186	0.0421	CbGeAlD
Dipivefrin—ADRA2C—uterus—polycystic ovary syndrome	0.000184	0.0415	CbGeAlD
Dipivefrin—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000181	0.0408	CbGeAlD
Dipivefrin—ADRA2C—adipose tissue—polycystic ovary syndrome	0.00018	0.0406	CbGeAlD
Dipivefrin—BCHE—uterus—polycystic ovary syndrome	0.000172	0.0388	CbGeAlD
Dipivefrin—ADRA1A—adrenal gland—polycystic ovary syndrome	0.00017	0.0382	CbGeAlD
Dipivefrin—BCHE—pituitary gland—polycystic ovary syndrome	0.000169	0.0381	CbGeAlD
Dipivefrin—BCHE—adipose tissue—polycystic ovary syndrome	0.000168	0.0379	CbGeAlD
Dipivefrin—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000162	0.0364	CbGeAlD
Dipivefrin—ADRA2A—endometrium—polycystic ovary syndrome	0.000159	0.036	CbGeAlD
Dipivefrin—BCHE—adrenal gland—polycystic ovary syndrome	0.000151	0.034	CbGeAlD
Dipivefrin—ADRA2C—female gonad—polycystic ovary syndrome	0.000151	0.034	CbGeAlD
Dipivefrin—ADRA2C—vagina—polycystic ovary syndrome	0.00015	0.0338	CbGeAlD
Dipivefrin—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000147	0.0332	CbGeAlD
Dipivefrin—ADRA2A—uterus—polycystic ovary syndrome	0.000147	0.0332	CbGeAlD
Dipivefrin—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000144	0.0326	CbGeAlD
Dipivefrin—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000144	0.0324	CbGeAlD
Dipivefrin—BCHE—vagina—polycystic ovary syndrome	0.00014	0.0315	CbGeAlD
Dipivefrin—BCHE—endocrine gland—polycystic ovary syndrome	0.000131	0.0295	CbGeAlD
Dipivefrin—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000129	0.0291	CbGeAlD
Dipivefrin—ADRA2A—female gonad—polycystic ovary syndrome	0.00012	0.0271	CbGeAlD
Dipivefrin—ADRA2A—vagina—polycystic ovary syndrome	0.000119	0.027	CbGeAlD
Dipivefrin—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000112	0.0252	CbGeAlD
Dipivefrin—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	2.22e-05	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	2.22e-05	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—SERPINE1—polycystic ovary syndrome	2.22e-05	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.22e-05	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.21e-05	0.000136	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	2.2e-05	0.000136	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.19e-05	0.000135	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.19e-05	0.000135	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	2.19e-05	0.000135	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	2.16e-05	0.000133	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.16e-05	0.000133	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.15e-05	0.000133	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.14e-05	0.000132	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FGF18—polycystic ovary syndrome	2.12e-05	0.000131	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.12e-05	0.000131	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	2.12e-05	0.000131	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CYP19A1—polycystic ovary syndrome	2.12e-05	0.000131	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.11e-05	0.00013	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AKR1C3—polycystic ovary syndrome	2.1e-05	0.00013	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RBP4—polycystic ovary syndrome	2.1e-05	0.00013	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.1e-05	0.00013	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	2.08e-05	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.07e-05	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CYP17A1—polycystic ovary syndrome	2.07e-05	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.07e-05	0.000128	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—TH—polycystic ovary syndrome	2.06e-05	0.000127	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.06e-05	0.000127	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.06e-05	0.000127	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	2.05e-05	0.000126	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	2.04e-05	0.000126	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	2.01e-05	0.000124	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	2.01e-05	0.000124	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2e-05	0.000123	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2e-05	0.000123	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.99e-05	0.000123	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.99e-05	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	1.98e-05	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	1.98e-05	0.000122	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.98e-05	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—YAP1—polycystic ovary syndrome	1.96e-05	0.000121	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	1.96e-05	0.000121	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	1.96e-05	0.000121	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.95e-05	0.00012	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—GAB1—polycystic ovary syndrome	1.94e-05	0.00012	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.92e-05	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	1.91e-05	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	1.9e-05	0.000117	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	1.9e-05	0.000117	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—GNAS—polycystic ovary syndrome	1.89e-05	0.000117	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	1.89e-05	0.000116	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.89e-05	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.88e-05	0.000116	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.86e-05	0.000115	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.86e-05	0.000115	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.85e-05	0.000114	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.85e-05	0.000114	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.85e-05	0.000114	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—INSR—polycystic ovary syndrome	1.85e-05	0.000114	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.84e-05	0.000113	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	1.84e-05	0.000113	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	1.84e-05	0.000113	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	1.83e-05	0.000113	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.83e-05	0.000113	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.83e-05	0.000113	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.81e-05	0.000112	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	1.81e-05	0.000112	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.81e-05	0.000112	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	1.81e-05	0.000112	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	1.8e-05	0.000111	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—NCOR1—polycystic ovary syndrome	1.8e-05	0.000111	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—TH—polycystic ovary syndrome	1.79e-05	0.000111	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.76e-05	0.000109	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.75e-05	0.000108	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—SLC2A4—polycystic ovary syndrome	1.74e-05	0.000108	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.73e-05	0.000107	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.72e-05	0.000106	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.72e-05	0.000106	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PGR—polycystic ovary syndrome	1.72e-05	0.000106	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	1.71e-05	0.000105	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.71e-05	0.000105	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.71e-05	0.000105	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.71e-05	0.000105	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CYP1A1—polycystic ovary syndrome	1.71e-05	0.000105	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.69e-05	0.000104	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.69e-05	0.000104	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.69e-05	0.000104	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—GNAS—polycystic ovary syndrome	1.68e-05	0.000104	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	1.68e-05	0.000104	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.68e-05	0.000104	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.64e-05	0.000101	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CYP19A1—polycystic ovary syndrome	1.64e-05	0.000101	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	1.63e-05	0.000101	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.63e-05	0.0001	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.62e-05	0.0001	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.62e-05	9.99e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.61e-05	9.92e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	1.61e-05	9.9e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.6e-05	9.84e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—GHRL—polycystic ovary syndrome	1.59e-05	9.84e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PLAT—polycystic ovary syndrome	1.59e-05	9.84e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—MTHFR—polycystic ovary syndrome	1.59e-05	9.81e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.59e-05	9.8e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.58e-05	9.75e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.57e-05	9.71e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.57e-05	9.67e-05	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.56e-05	9.63e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.54e-05	9.49e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.54e-05	9.48e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—VEGFA—polycystic ovary syndrome	1.53e-05	9.42e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	1.52e-05	9.39e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ATF1—polycystic ovary syndrome	1.52e-05	9.38e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.51e-05	9.34e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	1.5e-05	9.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.5e-05	9.27e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.5e-05	9.25e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.49e-05	9.21e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	1.49e-05	9.19e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.48e-05	9.15e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.48e-05	9.15e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.48e-05	9.11e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.47e-05	9.1e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	1.47e-05	9.07e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GNAS—polycystic ovary syndrome	1.46e-05	9.03e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TH—polycystic ovary syndrome	1.46e-05	8.98e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.44e-05	8.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.43e-05	8.82e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	1.42e-05	8.75e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.42e-05	8.74e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	1.42e-05	8.74e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.41e-05	8.72e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.41e-05	8.68e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	1.4e-05	8.66e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	1.4e-05	8.61e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	1.39e-05	8.6e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.39e-05	8.6e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.39e-05	8.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	1.39e-05	8.59e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	1.39e-05	8.58e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.34e-05	8.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.34e-05	8.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	1.33e-05	8.22e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.33e-05	8.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	1.32e-05	8.15e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.32e-05	8.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.31e-05	8.08e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.3e-05	8e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.3e-05	7.99e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.3e-05	7.99e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.29e-05	7.98e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.29e-05	7.96e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PPARG—polycystic ovary syndrome	1.29e-05	7.95e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—POMC—polycystic ovary syndrome	1.27e-05	7.84e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—INS—polycystic ovary syndrome	1.26e-05	7.8e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.25e-05	7.7e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.25e-05	7.7e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	1.24e-05	7.65e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.24e-05	7.62e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	1.23e-05	7.6e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.23e-05	7.6e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.23e-05	7.57e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.23e-05	7.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	1.22e-05	7.55e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.22e-05	7.52e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.22e-05	7.5e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.21e-05	7.46e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.2e-05	7.43e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.2e-05	7.4e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	1.19e-05	7.33e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.17e-05	7.23e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.17e-05	7.19e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.15e-05	7.12e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PPARG—polycystic ovary syndrome	1.15e-05	7.1e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	1.14e-05	7.06e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.14e-05	7.03e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—POMC—polycystic ovary syndrome	1.13e-05	7e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.13e-05	6.99e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	1.13e-05	6.99e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.13e-05	6.97e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—INS—polycystic ovary syndrome	1.13e-05	6.96e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.09e-05	6.72e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	1.07e-05	6.62e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.07e-05	6.61e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.07e-05	6.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.05e-05	6.47e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.04e-05	6.39e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.03e-05	6.34e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.02e-05	6.29e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.01e-05	6.25e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	1e-05	6.17e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1e-05	6.17e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	9.99e-06	6.16e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.94e-06	6.13e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	9.86e-06	6.08e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	9.8e-06	6.05e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—INS—polycystic ovary syndrome	9.8e-06	6.05e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	9.59e-06	5.92e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.47e-06	5.84e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.3e-06	5.73e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	9.16e-06	5.65e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	9.04e-06	5.58e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	8.82e-06	5.44e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	8.77e-06	5.41e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	8.71e-06	5.37e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	8.66e-06	5.34e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.57e-06	5.29e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	8.56e-06	5.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	8.49e-06	5.23e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	8.48e-06	5.23e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	8.39e-06	5.17e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	8.38e-06	5.17e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	8.37e-06	5.16e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	8.24e-06	5.08e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	8.2e-06	5.06e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	8.12e-06	5.01e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.06e-06	4.97e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	8.01e-06	4.94e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.96e-06	4.91e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—INS—polycystic ovary syndrome	7.96e-06	4.91e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.96e-06	4.91e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	7.93e-06	4.89e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	7.92e-06	4.89e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	7.79e-06	4.81e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.53e-06	4.64e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.48e-06	4.61e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	7.2e-06	4.44e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	7.16e-06	4.42e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.95e-06	4.29e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.93e-06	4.27e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.92e-06	4.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	6.69e-06	4.13e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	6.66e-06	4.11e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.58e-06	4.06e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	6.49e-06	4e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.44e-06	3.97e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.43e-06	3.97e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	6.41e-06	3.95e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.11e-06	3.77e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	6.06e-06	3.74e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.54e-06	3.42e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.47e-06	3.38e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.3e-06	3.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.18e-06	3.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.92e-06	3.04e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.53e-06	2.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.21e-06	2.59e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	3.83e-06	2.36e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	3.78e-06	2.33e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	3.58e-06	2.21e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.13e-06	1.93e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.91e-06	1.79e-05	CbGpPWpGaD
